Llwytho...
Current status of symptomatic medical therapy in Parkinson’s disease
Symptomatic medical therapies for Parkinson’s disease (PD) have been disease modifying and have led to improvement in daily function, quality of life, and survival. For 40 years, these therapies have been primarily dopaminergic, and currently include the dopamine (DA) precursor levodopa (LD), DA ago...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Neurotherapeutics |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer-Verlag
2008
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084161/ https://ncbi.nlm.nih.gov/pubmed/18394561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2007.12.001 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|